Chief Financial Officer
Diane Lu, CPA, is the Chief Financial Officer at Teclison. Since the company’s inception in 2013, she has served in several leadership roles that have been critical to establishing Teclison as an emerging clinical-stage player in the oncology space. Her career spans 30 years of varied experience in corporate strategy, financial management and business development. Diane is responsible for the company’s financial functions including corporate finance, accounting, investor relations, risk management, and negotiation of licensing deals. In this role, she has fostered strategic collaborations with Merck and out-licensing deal of Teclison’s lead asset, TEC-001, and secured a multi-million-dollar capital raise to further advance it into the clinic. Previously, Diane founded DCL, LLC., a consulting firm, where she provided financial and strategic guidance to companies on a range of business initiatives, including program management, accounting & tax planning, and regulatory compliance. Prior to DCL, LLC., she also founded a CPA firm and consulted with Ernst & Young and Arthur Anderson. Diane holds a Master of Accountancy from the Weatherhead School of Management at Case Western Reserve University. She is a Certified Public Accountant.